Advertisement
In addition, the Company will present at the Lazard Capital Markets FourthAnnual Health Care Conference in New York on Tuesday, November 27, 2007 atapproximately 4:30 p.m. Eastern Time, and at the 19th Annual Piper JaffrayHealth Care Conference in New York on Wednesday, November 28, 2007 atapproximately 10:30 a.m. Eastern Time.
Advertisement
Live webcasts of each event may be accessed on the investment informationsection of the Company's web site at http://www.gen-probe.com. Replays of thewebcasts will be available on the same web site for 30 days following theevents.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufactureand marketing of rapid, accurate and cost-effective nucleic acid tests (NATs)that are used primarily to diagnose human diseases and screen donated humanblood. Gen-Probe has more than 24 years of NAT expertise, and received the2004 National Medal of Technology, America's highest honor for technologicalinnovation, for developing NAT assays for blood screening. Gen-Probe isheadquartered in San Diego and employs approximately 1,000 people. For moreinformation, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs,plans, objectives, assumptions or future events or performance are nothistorical facts and are forward-looking statements. Forward-lookingstatements are not guarantees of performance. They involve known and unknownrisks, uncertainties and assumptions that may cause actual results, levels ofactivity, performance or achievements to differ materially from thoseexpressed or implied by any forward-looking statement. For information aboutrisks and uncertainties we face and a discussion of our financial statementsand footnotes, see documents we have filed with the SEC, including the Form10-Q for the period ended September 30, 2007, and all subsequent periodicfilings made with the SEC. We assume no obligation and expressly disclaim anyduty to update any forward-looking statement to reflect events orcircumstances after the date of this press release or to reflect theoccurrence of unanticipated events.
Paula Izidoro
Investor Relations
858-410-8904
SOURCE Gen-Probe Incorporated
